文献速递流行病学与生物统计医学教育与科研方法

阿拉伯语癌症患者临床试验参与障碍与促进因素:医护人员视角的定性研究

Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study.
PubMed 文献 · Trials · 2026-06-11

本研究通过虚拟焦点小组访谈14名有招募阿拉伯语癌症患者经验的医护人员,基于社会文化健康服务差异框架分析参与临床试验的结构性、提供者及环境层面障碍与促进因素。结果显示英语语言能力是核心障碍,翻译材料、延长咨询和 interpreter 参与可促进参与,家庭支持网络兼具促进与阻碍作用。

要点

  • 语言障碍削弱医护人员对患者理解试验信息和知情同意过程的信心
  • 提供翻译材料、延长咨询时间和安排口译员可促进阿拉伯语患者参与试验
  • 家庭支持网络既促进试验相关讨论,也可能损害患者决策自主性

核心结论

  • 上游社会健康决定因素可对澳大利亚阿拉伯语癌症患者参与临床试验构成障碍,减少其参与机会。
  • 所描述的障碍虽以语言形式呈现,但可能反映更广泛的文化能力不足。

研究设计与样本

  • 定性研究,采用虚拟焦点小组,通过专业网络和社交媒体以滚雪球抽样招募参与者。
  • 使用社会文化健康服务差异框架识别障碍与促进因素,由两名独立编码者采用Best Fit方法分析。

主要发现

  • 结构和医护人员障碍集中于英语语言能力。
  • 结构性障碍包括咨询时间有限、试验入选标准严格、缺乏翻译研究材料及 workforce 多样性不足。
  • 语言话语降低医护人员对患者理解试验信息及知情同意程序的信心。
  • 家庭支持网络作为环境促进因素促进试验相关对话,但也因损害患者决策自主性而成为障碍。
  • 感知的怀疑和痛苦作为环境障碍塑造了对癌症诊断和试验参与的态度。

临床怎么用

  • 医护人员可通过倡导翻译材料、预约更长咨询时间和安排口译员来促进阿拉伯语癌症患者参与临床试验。
  • 需关注家庭支持网络对患者决策自主性的潜在影响。
  • 研究设计应考虑整合时间、 workforce 多样性、口译员参与和翻译资源等促进因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Culturally and ethnically diverse communities are underrepresented in cancer clinical trials, further contributing to existing health inequities. Research often overlooks how upstream social determinants of health (SDOH) might contribute to these inequities, instead focusing on individual-level barriers. Arabic is the third most spoken language in Australia and is the focus of this study. This study aims to explore how upstream SDOH influence clinical trial participation among Arabic-speaking cancer patients (ASCPs), as perceived by healthcare professionals (HCPs). METHODS: A qualitative study comprising virtual focus groups with HCPs with experience recruiting ASCPs into clinical trials. Participants were recruited via professional networks and social media using snowball sampling. The Sociocultural Framework for Health Service Disparities was used to identify perceived barriers and enablers to cancer clinical trial participation relating to structural, healthcare provider, and environmental factors. Focus groups were analysed using the Best Fit approach by two independent coders. RESULTS: Fourteen participants were recruited (ten medical specialists, two nurses, one clinical trial coordinator and one researcher). Structural and healthcare provider barriers centred on English-language proficiency. Structural barriers included limited consultation time, restrictive trial eligibility criteria, lack of translated study materials, and a lack of workforce diversity. Language discourse reduced HCPs' confidence in patient understanding of trial information and consequently the informed consent procedure. By advocating for translated materials, booking longer consults, and engaging interpreters, HCPs became enablers to trial participation. Family support networks were identified as environmental enablers by facilitating trial-related conversations; however, they also acted as barriers by compromising patient autonomy in decision-making. Perceived scepticism and distress emerged as environmental barriers that shaped attitudes toward cancer diagnosis and trial participation. CONCLUSION: Findings highlight how upstream SDOH can create barriers to cancer clinical trial access, thereby reducing opportunities for participation among ASCPs in Australia. Although the barriers were described in terms of language, they may reflect a broader lack of cultural competency. Further research into strategies integrating enablers such as time, workforce diversity, interpreter engagement and translated resources is essential to inform inclusive healthcare systems and research design, with potential implications beyond the Arabic-speaking community. TRIAL REGISTRATION: Ethical approval for this study was granted by the University of Technology Sydney Human Research Ethics Committee (ETH21-6506, 14/01/2022).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Saleh Moussa R, Edwards LM, Camit M, et al. Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study. Trials. 2026. PMID: 42277890. doi:10.1186/s13063-026-09815-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。